Newsfeeds - Spark Newswire

2 minute read

Biotech
FDA
General
News

Ampio Pharmaceuticals Receives Approval To Expand Enrollment Of AP-019 Phase II Study To India

Today, 8:00 AM

Ampio Pharmaceuticals (NYSE:AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced it has received regulatory approval to

AMPE

26 minute read

Uncategorized

Earnings Scheduled For May 5, 2021

By Benzinga Insights

Today, 8:00 AM

Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter.

AAWW

8 minute read

Uncategorized

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge

By Shanthi Rexaline

Today, 8:00 AM

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions.

ABUS

Latest news

Ampio Pharmaceuticals Receives Approval To Expand Enrollment Of AP-019 Phase II Study To India

Earnings Scheduled For May 5, 2021

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge